WallabyPhenox

WallabyPhenox is a global medical technology company dedicated to innovative solutions for treating neurovascular diseases, particularly ischemic and hemorrhagic strokes. The company emerged from phenox GmbH, founded in Germany in 2005, and was rebranded after being acquired by Wallaby Medical in 2022. This merger combines expertise from both organizations to enhance stroke treatment worldwide. The company offers a range of advanced medical devices for endovascular specialists, including the Mechanical Thrombectomy System pRESET for removing blood clots, various Flow Diverters for treating complex intracranial aneurysms, and the pCONUS Implant for managing wide-neck bifurcation aneurysms. WallabyPhenox also features the HPC Technology to improve patient safety and distributes the Avenir Coiling System. With a strong focus on research and development, WallabyPhenox is committed to evidence-based medicine and improving patient outcomes through clinical trials and innovative product development. Their products are utilized by healthcare providers and hospitals globally, aiming to provide effective treatment options for stroke and aneurysm patients.

• Employees 180
• Founded 2005
• Annual Revenue $15000000